Is ASBP or ASRT more undervalued in 2026?

CirclFi compares Aspire Biopharma Holdings, Inc. (ASBP) and Assertio Holdings, Inc. (ASRT) using 13 institutional-grade valuation models. ASBP has a Quality of Company score of 4.6/10 while ASRT scores 5.4/10.

Which is a better buy — ASBP or ASRT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ASBP and ASRT valuations compare?

ASBP at $5.49 and ASRT at $23.44 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ASBP vs ASRT Valuation Comparison 2026 — Intrinsic Value Analysis

ASBP

Pharmaceutical Preparations

Aspire Biopharma Holdings, Inc.

Quality

4.6

out of 10

Value Trap

SAFE

Price

$5.49

Last close

Models

8/13

Active

ASRT

Pharmaceutical Preparations

Assertio Holdings, Inc.

Quality

5.4

out of 10

Value Trap

SAFE

Price

$23.44

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	ASBP Fair Value	ASBP Upside	ASRT Fair Value	ASRT Upside
Bayesian DCF	Intrinsic	$3.94	-28.2%	$50.66	+116.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.01	-95.5%	$5.55	-69.9%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$7.67	+39.7%	$37.27	+59.0%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ASBP vs ASRT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ASBP vs ASRT — Which Stock Is More Undervalued?

ASRT scores higher with a 5.4/10 quality rating vs ASBP's 4.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Aspire Biopharma Holdings, Inc. (ASBP) and Assertio Holdings, Inc. (ASRT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ASBP currently trades at $5.49 with a QOC of 4.6/10, while ASRT trades at $23.44 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).